Jianfeng Pharmaceutical Went to Pair Villages to Teach to Increase Income and Disclose Thins to Common Wealth
Release time:
2022-11-01
News from our newspaper In order to implement the work plan of "Thousand Regiment Union Thousand Village " Co-construction and Co-prosperity, 10# August 26 , dai Jinxiao, deputy secretary of the Party Committee of Jianfeng Pharmaceutical Company, and Chen Qixi, member of the Party Committee of the Municipal Supply and Marketing Cooperative and deputy director of the Council, led "Village Helping Group " members to the twinning village - Taosi Village, Tangxi Town, Jinhua Development Zone to jointly carry out "Thousand Regiment Union Thousand Village " Co-construction and Co-prosperity.
In May this year, according to the unified arrangement of the city, Jianfeng Pharmaceutical, together with the municipal supply and marketing cooperatives and the special commissioners of various units directly under the municipal government, formed "Village Helping Group " , and paired with Taosi Village in Tangxi Town to carry out "Thousand Regiment United Thousand Villages " to build a common prosperity. This is the third time to carry out relevant actions in Taosi Village, Tangxi Town. Taosi Village is an immigrant village with limited collective resources and weak economy.
"Village Helping Group " and its party had a discussion and exchange with the two committees of Taosi Village and the cadres stationed in the village, and learned in detail about the infrastructure, collective economy, resource advantages, villagers' employment and other conditions of Taosi Village as well as the difficulties and problems they are facing, and on financial services, financial support, legal aid, "to build a common wealth " publicity and other aspects of the analysis and discussion, put forward relevant opinions and suggestions. Everyone made concerted efforts to actively seek the entrance to promote the growth and reduction of Taosi Village's income and common prosperity, and jointly explore the path of rural revitalization. At the symposium, Dai Jinxiao, on behalf of Jianfeng Pharmaceutical, said that he would do his best to help Taosi Village with the municipal supply and marketing cooperatives and actively provide
"post " service for Taosi Village to create job opportunities. In the next step, "village help group " will also further strengthen the docking and communication with village cadres and villagers, do a good job in the employment investigation of party members and villagers, and carry out "six send six help " in a targeted manner to give full play to the advantages of various parties, actively coordinate the relevant departments to implement the village road "white to black " project funds, work together to help strengthen the village and enrich the people, and gradually realize common prosperity. (Jiang Wenqing)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page